May 26, 2021
Collaboration takes a Silicon Valley approach to the Quadruple Aim, setting new standard for modern healthcare with end-to-end cloud-based interoperability and innovative AI
Amsterdam, the Netherlands and
–
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University of California, San Francisco (UCSF), a world-class biomedical research hub and health system, today announced a partnership to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for healthcare delivery.
UCSF will use
Philips HealthSuite to oversee the development of technologies that leverage Artificial Intelligence to enable personalization and make it easier for patients to select providers, access their health information and receive virtual care at home, while also easing the burden on care providers with intuitive workflows and real-time decision support. Philips’ open API-based ecosystem will f
May 26, 2021 Collaboration takes a Silicon Valley approach to the Quadruple Aim, setting new standard for modern healthcare with end-to-end cloud-based interoperability and innovative AI Amsterdam
Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center
Thermo Fisher Scientific Inc. the world leader in serving science, and the University of California, San Francisco today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will build and operate a 44,000-square-foot, state-of-the-art cell therapy development, manufacturing and collaboration center in leased space …
– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies.